Lupin Ltd. Faces Continued Stock Decline Amid Broader Market Weakness

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable decline of 3.0% on May 20, 2025. The stock has underperformed the sector by 1.93%, marking its fourth consecutive day of losses, with a total drop of 5.21% over this period. Today, Lupin reached an intraday low of Rs 1962.7, reflecting a decrease of 3.26%.
In terms of moving averages, Lupin is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 4.61%, contrasting with the Sensex's slight gain of 0.05%.

Looking at broader market trends, the Sensex fell sharply by 929.73 points to close at 81,186.44, down 1.06% after a flat opening. While Lupin has shown a year-to-date performance decline of 16.21%, it has outperformed the Sensex over the past year with an 18.67% increase compared to the index's 9.70%. However, over longer periods, such as three and five years, Lupin's performance remains strong, with increases of 208.55% and 125.53%, respectively.